Stock’s Earning Overview Calithera Biosciences, Inc.(NASDAQ:CALA): R.R. Donnelley & Sons Company(NASDAQ:RRD)

0
4

Calithera Biosciences, Inc. (CALA) will report its next earnings on Nov 07 AMC. The company reported the earnings of $-0.52/Share in the last quarter where the estimated EPS by analysts was $-0.4/share. The difference between the expected and actual EPS was $-0.12/share, which represents an Earnings surprise of -30%.

Many analysts are providing their Estimated Earnings analysis for Calithera Biosciences, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.49/share. These analysts have also projected a Low Estimate of $-0.58/share and a High Estimate of $-0.34/share.

These analysts also forecasted Growth Estimates for the Current Quarter for CALA to be -54.8%. They are projecting Next Quarter growth of -29.73%. For the next 5 years, Calithera Biosciences, Inc. is expecting Growth of -29.22% per annum, whereas in the past 5 years the growth was -73.81% per annum.

Some buy side analysts are also providing their Analysis on Calithera Biosciences, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Calithera Biosciences, Inc. might touch $20 high while the Average Price Target and Low price Target is $14 and $10 respectively.

Calithera Biosciences, Inc. closed its last trading session at $5.04 with the gain of 0%. The Market Capitalization of the company stands at 188.19 Million. The Company has 52-week high of $10.18 and 52-week low of $4.05. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 2.11% where SMA50 and SMA200 are -2.34% and -8.61% respectively. The Company Touched its 52-Week High on 12/06/17 and 52-Week Low on 07/30/18.

The Relative Volume of the company is 1.12 and Average Volume (3 months) is 358.4 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -27.2%. The Return on Equity (ROE) value stands at -31.7%. While it’s Return on Investment (ROI) value is -19.8%.

While looking at the Stock’s Performance, Calithera Biosciences, Inc. currently shows a Weekly Performance of 11.26%, where Monthly Performance is 2.02%, Quarterly performance is -5.79%, 6 Months performance is -4.91% and yearly performance percentage is -48.31%. Year to Date performance value (YTD perf) value is -39.64%. The Stock currently has a Weekly Volatility of 7.43% and Monthly Volatility of 7.83%.

R.R. Donnelley & Sons Company (RRD) will report its next earnings on Oct 30 AMC. The company reported the earnings of $0.25/Share in the last quarter where the estimated EPS by analysts was $0.25/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for R.R. Donnelley & Sons Company and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for R.R. Donnelley & Sons Company as 1.78 Billion. According to these analysts, the Low Revenue Estimate for R.R. Donnelley & Sons Company is 1.77 Billion and the High Revenue Estimate is 1.79 Billion. The company had Year Ago Sales of 1.93 Billion.

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for R.R. Donnelley & Sons Company might touch $8 high while the Average Price Target and Low price Target is $8 and $8 respectively.

R.R. Donnelley & Sons Company closed its last trading session at $5.87 with the gain of 0%. The Market Capitalization of the company stands at 408.02 Million. The Company has 52-week high of $9.79 and 52-week low of $4.09. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -6.07% where SMA50 and SMA200 are 7.69% and -8.34% respectively. The Company Touched its 52-Week High on 01/12/18 and 52-Week Low on 10/12/18.

The Relative Volume of the company is 0.69 and Average Volume (3 months) is 982.65 million. The company’s P/E (price to earnings) ratio is 5.99 and Forward P/E ratio of 6.21.

The company shows its Return on Assets (ROA) value of -1.1%. The Return on Equity (ROE) value stands at 17.9%. While it’s Return on Investment (ROI) value is 11%.

While looking at the Stock’s Performance, R.R. Donnelley & Sons Company currently shows a Weekly Performance of -5.93%, where Monthly Performance is -8.85%, Quarterly performance is 3.71%, 6 Months performance is -8.42% and yearly performance percentage is -34.19%. Year to Date performance value (YTD perf) value is -36.88%. The Stock currently has a Weekly Volatility of 5.06% and Monthly Volatility of 4.86%.

SHARE